Recode Therapeutics has filed a notice of an exempt offering of securities to raise $220,801,112.00 in Equity and Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Recode Therapeutics is raising $220,801,112.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Shehnaaz Suliman played a key role in…
